Principal Scientist at Recursion leading oncology drug discovery programs. Role integrates AI/ML-driven platforms with traditional drug discovery, managing small molecule programs from hit to IND submission within a cross-functional biotech team.
The Impact You'll Make
Recursion is at the forefront of reimagining drug discovery by integrating technological innovations across biology, chemistry, automation, data science, and engineering to radically improve lives by industrializing drug discovery. We are seeking an experienced Associate Director to join our Discovery Biology team to lead and advance our AI-driven portfolio of therapeutic candidates.
This is a truly unique opportunity to work at the dynamic intersection of technology and biology. You won't just manage projects and key initiatives; you will be an active catalyst contributing to the evolution of a new, powerful paradigm in medicine.
In this Role, You Will:
The Team You'll Join
You will be an integral part of the Discovery team, working collaboratively with a diverse group of life scientists, computational and technical experts. You will work cross-functionally with team members from various disciplines, including data science, computational biology, pharmacology, DMPK, and chemistry, to accelerate the progression of compounds through the portfolio. This team is responsible for guiding the foundational biology and the critical "tech-to-program" translation across our early Discovery oncology portfolio.
The Experience You'll Need
Working Location:
This is an office-based, hybrid role in our Salt Lake City / New York City office. Employees are expected to work in the office at least 50% of the time.
At Recursion, we believe that every employee should be compensated fairly. Based on the skill and level of experience required for this role, the estimated current annual base range for this role is $198,000 - $271,700 (USD). You will also be eligible for an annual bonus and equity compensation, as well as a comprehensive benefits package.
#LI-EP1
The Values We Hope You Share:
Our values underpin the employee experience at Recursion. They are the character and personality of the company demonstrated through how we communicate, support one another, spend our time, make decisions, and celebrate collectively.
More About Recursion
Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.
Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn more at www.recursion.com, or connect on X and LinkedIn.
Recursion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal, state, local, or provincial human rights legislation.
Accommodations are available on request for candidates taking part in all aspects of the selection process.